KYLE HUME D. 4

What Happened

• Director Kyle Hume received a grant of derivative awards covering 38,200 shares (reported as an acquisition, transaction code A) on February 2, 2026. The filing shows $0 cash paid for the award (typical for grants); the underlying exercise price was reported in a footnote as C$11.87, which converts to about US$8.75 per share using the stated exchange rate.

Key Details

• Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (filed within the usual 2-business-day window).
• Reported consideration: $0.00 in the filing (award/grant); underlying exercise price: C$11.87 ≈ US$8.75 (footnote F1).
• Vesting: 1/3 vests on 02/02/2027, 1/3 on 02/02/2028, and 1/3 on 02/02/2029 (footnote F2).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Transaction type: Award/derivative grant (not an open-market buy or sale).

Context

• This was a compensation-style grant to a company director, not an immediate cash purchase or sale. The award will vest over three years; exercising the underlying options would require payment of the stated exercise price per share. Such grants are common for director compensation and retention and do not by themselves indicate a buy or sell signal by the insider.